Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001029142-25-000037
Filing Date
2025-02-18
Accepted
2025-02-18 17:13:00
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739916772.html 4  
1 FORM 4 wk-form4_1739916772.xml 4 13565
  Complete submission text file 0001029142-25-000037.txt   14993
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 39 YORKSHIRE DR OAKLAND CA 94618
Business Address
Novack David F (Reporting) CIK: 0001573072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 25636094